{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:00:23Z","timestamp":1791198023379,"version":"4.1.0"},"reference-count":73,"publisher":"Elsevier BV","issue":"16","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T00:00:00Z","timestamp":1599436800000},"content-version":"vor","delay-in-days":2351,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R01AG046205"],"award-info":[{"award-number":["R01AG046205"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R01AG035355"],"award-info":[{"award-number":["R01AG035355"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R01AG027924"],"award-info":[{"award-number":["R01AG027924"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["P01AG030128"],"award-info":[{"award-number":["P01AG030128"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["P01NS074969"],"award-info":[{"award-number":["P01NS074969"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1074\/jbc.m113.526095","type":"journal-article","created":{"date-parts":[[2014,3,6]],"date-time":"2014-03-06T04:40:19Z","timestamp":1394080819000},"page":"11282-11292","source":"Crossref","is-referenced-by-count":67,"title":["Retinoic Acid Isomers Facilitate Apolipoprotein E Production and Lipidation in Astrocytes through the Retinoid X Receptor\/Retinoic Acid Receptor Pathway"],"prefix":"10.1016","volume":"289","author":[{"given":"Jing","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Chen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuru","family":"Shinohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrietta M.","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahisa","family":"Kanekiyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guojun","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.M113.526095_bib1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1750-1326-6-27","article-title":"Biology and pathophysiology of the amyloid precursor protein","volume":"6","author":"Zheng","year":"2011","journal-title":"Mol. Neurodegener"},{"key":"10.1074\/jbc.M113.526095_bib2","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"10.1074\/jbc.M113.526095_bib3","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(06)69113-7","article-title":"Alzheimer's disease","volume":"368","author":"Blennow","year":"2006","journal-title":"Lancet"},{"key":"10.1074\/jbc.M113.526095_bib4","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jalz.2013.02.003","article-title":"2013 Alzheimer's disease facts and figures","volume":"9","author":"Thies","year":"2013","journal-title":"Alzheimers Dement"},{"key":"10.1074\/jbc.M113.526095_bib5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1750-1326-8-19","article-title":"TREM2 in neurodegeneration: Evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson's disease","volume":"8","author":"Rayaprolu","year":"2013","journal-title":"Mol. Neurodegener"},{"key":"10.1074\/jbc.M113.526095_bib6","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families","volume":"261","author":"Corder","year":"1993","journal-title":"Science"},{"key":"10.1074\/jbc.M113.526095_bib7","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1073\/pnas.90.5.1977","article-title":"Apolipoprotein E: High-avidity binding to \u03b2-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease","volume":"90","author":"Strittmatter","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.M113.526095_bib8","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","article-title":"Apolipoprotein E and Alzheimer disease: Risk, mechanisms and therapy","volume":"9","author":"Liu","year":"2013","journal-title":"Nat. Rev. Neurol"},{"key":"10.1074\/jbc.M113.526095_bib9","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.neuron.2014.01.045","article-title":"ApoE and A\u03b2 in Alzheimer's disease: Accidental encounters or partners?","volume":"81","author":"Kanekiyo","year":"2014","journal-title":"Neuron"},{"key":"10.1074\/jbc.M113.526095_bib10","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.cell.2012.02.040","article-title":"Alzheimer mechanisms and therapeutic strategies","volume":"148","author":"Huang","year":"2012","journal-title":"Cell"},{"key":"10.1074\/jbc.M113.526095_bib11","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.neuron.2009.06.026","article-title":"The role of apolipoprotein E in Alzheimer's disease","volume":"63","author":"Kim","year":"2009","journal-title":"Neuron"},{"key":"10.1074\/jbc.M113.526095_bib12","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.bbrc.2009.08.020","article-title":"MicroRNA-205 inhibits tumor cell migration through down-regulating the expression of the LDL receptor-related protein 1","volume":"388","author":"Song","year":"2009","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"10.1074\/jbc.M113.526095_bib13","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1750-1326-8-16","article-title":"ApoE4 induces A\u03b242, tau, and neuronal pathology in the hippocampus of young targeted replacement apoE4 mice","volume":"8","author":"Liraz","year":"2013","journal-title":"Mol. Neurodegener"},{"key":"10.1074\/jbc.M113.526095_bib14","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.bbalip.2010.02.007","article-title":"Formation and function of apolipoprotein E-containing lipoproteins in the nervous system","volume":"1801","author":"Vance","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1074\/jbc.M113.526095_bib15","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1007\/s00018-003-3018-7","article-title":"Cholesterol homeostasis and function in neurons of the central nervous system","volume":"60","author":"Pfrieger","year":"2003","journal-title":"Cell. Mol. Life Sci"},{"key":"10.1074\/jbc.M113.526095_bib16","doi-asserted-by":"crossref","first-page":"4558","DOI":"10.1093\/hmg\/dds296","article-title":"Cerebrospinal fluid APOE levels: An endophenotype for genetic studies for Alzheimer's disease","volume":"21","author":"Cruchaga","year":"2012","journal-title":"Hum. Mol. Genet"},{"key":"10.1074\/jbc.M113.526095_bib17","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1001\/archneur.61.5.705","article-title":"Relation of plasma lipids to Alzheimer disease and vascular dementia","volume":"61","author":"Reitz","year":"2004","journal-title":"Arch. Neurol"},{"key":"10.1074\/jbc.M113.526095_bib18","doi-asserted-by":"crossref","first-page":"34144","DOI":"10.1074\/jbc.M110.108100","article-title":"ATP-binding cassette transporter A1 mediates the beneficial effects of the liver X receptor agonist GW3965 on object recognition memory and amyloid burden in amyloid precursor protein\/presenilin 1 mice","volume":"285","author":"Donkin","year":"2010","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.526095_bib19","doi-asserted-by":"crossref","first-page":"6862","DOI":"10.1523\/JNEUROSCI.1051-10.2010","article-title":"Liver X receptor agonist treatment ameliorates amyloid pathology and memory deficits caused by high-fat diet in APP23 mice","volume":"30","author":"Fitz","year":"2010","journal-title":"J. Neurosci"},{"key":"10.1074\/jbc.M113.526095_bib20","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.1074\/jbc.M411420200","article-title":"The liver X receptor ligand T0901317 decreases amyloid \u03b2 production in vitro and in a mouse model of Alzheimer's disease","volume":"280","author":"Koldamova","year":"2005","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.526095_bib21","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1126\/science.1217697","article-title":"ApoE-directed therapeutics rapidly clear \u03b2-amyloid and reverse deficits in AD mouse models","volume":"335","author":"Cramer","year":"2012","journal-title":"Science"},{"key":"10.1074\/jbc.M113.526095_bib22","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1194\/jlr.M500116-JLR200","article-title":"Synthetic LXR agonists increase LDL in CETP species","volume":"46","author":"Groot","year":"2005","journal-title":"J. Lipid Res"},{"key":"10.1074\/jbc.M113.526095_bib23","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.nbd.2004.11.005","article-title":"Production and characterization of astrocyte-derived human apolipoprotein E isoforms from immortalized astrocytes and their interactions with amyloid-\u03b2","volume":"19","author":"Morikawa","year":"2005","journal-title":"Neurobiol. Dis"},{"key":"10.1074\/jbc.M113.526095_bib24","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.neuron.2007.08.008","article-title":"Amyloid precursor protein regulates brain apolipoprotein E and cholesterol metabolism through lipoprotein receptor LRP1","volume":"56","author":"Liu","year":"2007","journal-title":"Neuron"},{"key":"10.1074\/jbc.M113.526095_bib25","article-title":"Isolation and purification of primary rodent astrocytes","author":"Weinstein","year":"2001","journal-title":"Curr. Protoc. Neurosci"},{"key":"10.1074\/jbc.M113.526095_bib26","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/S0022-2275(20)38434-0","article-title":"Heterogeneity of apolipoprotein E epitope expression on human lipoproteins: Importance for apolipoprotein E function","volume":"29","author":"Krul","year":"1988","journal-title":"J. Lipid Res"},{"key":"10.1074\/jbc.M113.526095_bib27","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1750-1326-2-7","article-title":"Apolipoprotein E levels in cerebrospinal fluid and the effects of ABCA1 polymorphisms","volume":"2","author":"Wahrle","year":"2007","journal-title":"Mol. Neurodegener"},{"key":"10.1074\/jbc.M113.526095_bib28","doi-asserted-by":"crossref","first-page":"44593","DOI":"10.1074\/jbc.M112.420224","article-title":"Differential regulation of amyloid-\u03b2 endocytic trafficking and lysosomal degradation by apolipoprotein E isoforms","volume":"287","author":"Li","year":"2012","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.526095_bib29","doi-asserted-by":"crossref","first-page":"30001","DOI":"10.1074\/jbc.274.42.30001","article-title":"Unique lipoproteins secreted by primary astrocytes from wild type, apoE (\u2212\/\u2212), and human apoE transgenic mice","volume":"274","author":"Fagan","year":"1999","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.526095_bib30","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/1531-8249(200008)48:2<201::AID-ANA10>3.0.CO;2-X","article-title":"Differences in the A\u03b240\/A\u03b242 ratio associated with cerebrospinal fluid lipoproteins as a function of apolipoprotein E genotype","volume":"48","author":"Fagan","year":"2000","journal-title":"Ann. Neurol"},{"key":"10.1074\/jbc.M113.526095_bib31","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1124\/jpet.111.182196","article-title":"Retinoic acid isomers up-regulate ATP binding cassette A1 and G1 and cholesterol efflux in rat astrocytes: Implications for their therapeutic and teratogenic effects","volume":"338","author":"Chen","year":"2011","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"10.1074\/jbc.M113.526095_bib32","doi-asserted-by":"crossref","first-page":"15299","DOI":"10.1074\/jbc.M807285200","article-title":"Cooperative folding and ligand-binding properties of LRP6 \u03b2-propeller domains","volume":"284","author":"Liu","year":"2009","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.526095_bib33","doi-asserted-by":"crossref","first-page":"258","DOI":"10.2340\/00015555-1359","article-title":"Ten-year experience of bexarotene therapy for cutaneous T-cell lymphoma in Finland","volume":"92","author":"V\u00e4kev\u00e4","year":"2012","journal-title":"Acta Derm. Venereol"},{"key":"10.1074\/jbc.M113.526095_bib34","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1002\/glia.21004","article-title":"Astrocytic A\u03b2 1\u201342 uptake is determined by A\u03b2-aggregation state and the presence of amyloid-associated proteins","volume":"58","author":"Nielsen","year":"2010","journal-title":"Glia"},{"key":"10.1074\/jbc.M113.526095_bib35","doi-asserted-by":"crossref","first-page":"31491","DOI":"10.1074\/jbc.M205016200","article-title":"Activation of retinoic acid receptor-dependent transcription by all-trans-retinoic acid metabolites and isomers","volume":"277","author":"Idres","year":"2002","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.526095_bib36","doi-asserted-by":"crossref","first-page":"S129","DOI":"10.1067\/mjd.2001.113714","article-title":"Cellular metabolism and actions of 13-cis-retinoic acid","volume":"45","author":"Blaner","year":"2001","journal-title":"J. Am. Acad. Dermatol"},{"key":"10.1074\/jbc.M113.526095_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gene.2003.12.005","article-title":"Nuclear retinoid receptors and the transcription of retinoid-target genes","volume":"328","author":"Bastien","year":"2004","journal-title":"Gene"},{"key":"10.1074\/jbc.M113.526095_bib38","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1124\/pr.58.4.7","article-title":"International Union of Pharmacology. LXIII. Retinoid X receptors","volume":"58","author":"Germain","year":"2006","journal-title":"Pharmacol. Rev"},{"key":"10.1074\/jbc.M113.526095_bib39","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1124\/pr.58.4.4","article-title":"International Union of Pharmacology. LX. Retinoic acid receptors","volume":"58","author":"Germain","year":"2006","journal-title":"Pharmacol. Rev"},{"key":"10.1074\/jbc.M113.526095_bib40","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1101\/gad.9.9.1033","article-title":"LXR, a nuclear receptor that defines a distinct retinoid response pathway","volume":"9","author":"Willy","year":"1995","journal-title":"Genes Dev"},{"key":"10.1074\/jbc.M113.526095_bib41","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1096\/fasebj.10.9.8801176","article-title":"A decade of molecular biology of retinoic acid receptors","volume":"10","author":"Chambon","year":"1996","journal-title":"FASEB J"},{"key":"10.1074\/jbc.M113.526095_bib42","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/dvdy.10222","article-title":"Retinoic acid, a regeneration-inducing molecule","volume":"226","author":"Maden","year":"2003","journal-title":"Dev. Dyn"},{"key":"10.1074\/jbc.M113.526095_bib43","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1001\/archneur.64.12.1706","article-title":"Functional implication of the vitamin A signaling pathway in the brain","volume":"64","author":"Tafti","year":"2007","journal-title":"Arch. Neurol"},{"key":"10.1074\/jbc.M113.526095_bib44","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0306-4522(02)00423-2","article-title":"Vitamin A deficiency produces spatial learning and memory impairment in rats","volume":"115","author":"Cocco","year":"2002","journal-title":"Neuroscience"},{"key":"10.1074\/jbc.M113.526095_bib45","doi-asserted-by":"crossref","first-page":"302","DOI":"10.2174\/156720509788486581","article-title":"Towards retinoid therapy for Alzheimer's disease","volume":"6","author":"Shudo","year":"2009","journal-title":"Curr. Alzheimer Res"},{"key":"10.1074\/jbc.M113.526095_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0197-0186(99)00101-1","article-title":"Inhibition of glutathione depletion by retinoic acid and tocopherol protects cultured neurons from staurosporine-induced oxidative stress and apoptosis","volume":"36","author":"Ahlemeyer","year":"2000","journal-title":"Neurochem. Int"},{"key":"10.1074\/jbc.M113.526095_bib47","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/jnr.21865","article-title":"9-cis-Retinoic acid reduces ischemic brain injury in rodents via bone morphogenetic protein","volume":"87","author":"Shen","year":"2009","journal-title":"J. Neurosci. Res"},{"key":"10.1074\/jbc.M113.526095_bib48","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3233\/JAD-1999-14-501","article-title":"Dietary links to Alzheimer's disease: 1999 update","volume":"1","author":"Grant","year":"1999","journal-title":"J. Alzheimers Dis"},{"key":"10.1074\/jbc.M113.526095_bib49","doi-asserted-by":"crossref","first-page":"11622","DOI":"10.1523\/JNEUROSCI.3153-08.2008","article-title":"Retinoic acid attenuates \u03b2-amyloid deposition and rescues memory deficits in an Alzheimer's disease transgenic mouse model","volume":"28","author":"Ding","year":"2008","journal-title":"J. Neurosci"},{"key":"10.1074\/jbc.M113.526095_bib50","doi-asserted-by":"crossref","first-page":"13244","DOI":"10.1074\/jbc.M300044200","article-title":"22R-Hydroxycholesterol and 9-cis-retinoic acid induce ATP-binding cassette transporter A1 expression and cholesterol efflux in brain cells and decrease amyloid \u03b2 secretion","volume":"278","author":"Koldamova","year":"2003","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.526095_bib51","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1750-1326-8-34","article-title":"Cross-talk of membrane lipids and Alzheimer-related proteins","volume":"8","author":"Walter","year":"2013","journal-title":"Mol. Neurodegener"},{"key":"10.1074\/jbc.M113.526095_bib52","doi-asserted-by":"crossref","first-page":"40987","DOI":"10.1074\/jbc.M407963200","article-title":"ABCA1 is required for normal central nervous system ApoE levels and for lipidation of astrocyte-secreted apoE","volume":"279","author":"Wahrle","year":"2004","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.526095_bib53","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0022-2275(20)31566-2","article-title":"ABCA1. The gatekeeper for eliminating excess tissue cholesterol","volume":"42","author":"Oram","year":"2001","journal-title":"J. Lipid Res"},{"key":"10.1074\/jbc.M113.526095_bib54","doi-asserted-by":"crossref","first-page":"4049","DOI":"10.1074\/jbc.M508915200","article-title":"Expression of ABCG1, but not ABCA1, correlates with cholesterol release by cerebellar astroglia","volume":"281","author":"Karten","year":"2006","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.526095_bib55","doi-asserted-by":"crossref","first-page":"9774","DOI":"10.1073\/pnas.0403506101","article-title":"ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins","volume":"101","author":"Wang","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.M113.526095_bib56","doi-asserted-by":"crossref","first-page":"43243","DOI":"10.1074\/jbc.M508781200","article-title":"The absence of ABCA1 decreases soluble apoE levels but does not diminish amyloid deposition in two murine models of Alzheimer disease","volume":"280","author":"Hirsch-Reinshagen","year":"2005","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.526095_bib57","doi-asserted-by":"crossref","first-page":"43224","DOI":"10.1074\/jbc.M504513200","article-title":"Lack of ABCA1 considerably decreases brain apoE level and increases amyloid deposition in APP23 mice","volume":"280","author":"Koldamova","year":"2005","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.526095_bib58","doi-asserted-by":"crossref","first-page":"43236","DOI":"10.1074\/jbc.M508780200","article-title":"Deletion of Abca1 increases A\u03b2 deposition in the PDAPP transgenic mouse model of Alzheimer disease","volume":"280","author":"Wahrle","year":"2005","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.526095_bib59","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/biof.37","article-title":"Greasing the wheels of A\u03b2 clearance in Alzheimer's disease: the role of lipids and apolipoprotein E","volume":"35","author":"Fan","year":"2009","journal-title":"Biofactors"},{"key":"10.1074\/jbc.M113.526095_bib60","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.bbalip.2010.02.010","article-title":"The role of ATP-binding cassette transporter A1 in Alzheimer's disease and neurodegeneration","volume":"1801","author":"Koldamova","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1074\/jbc.M113.526095_bib61","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0896-6273(03)00850-X","article-title":"ApoE and clusterin cooperatively suppress A\u03b2 levels and deposition: evidence that ApoE regulates extracellular A\u03b2 metabolism in vivo","volume":"41","author":"DeMattos","year":"2004","journal-title":"Neuron"},{"key":"10.1074\/jbc.M113.526095_bib62","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/372092a0","article-title":"Amyloid-associated proteins \u03b11-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer \u03b2-protein into filaments","volume":"372","author":"Ma","year":"1994","journal-title":"Nature"},{"key":"10.1074\/jbc.M113.526095_bib63","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nm1058","article-title":"Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-\u03b2 peptides","volume":"10","author":"Koistinaho","year":"2004","journal-title":"Nat. Med"},{"key":"10.1074\/jbc.M113.526095_bib64","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1385\/JMN:23:3:235","article-title":"ApoE and A\u03b21\u201342 interactions: effects of isoform and conformation on structure and function","volume":"23","author":"Manelli","year":"2004","journal-title":"J. Mol. Neurosci"},{"key":"10.1074\/jbc.M113.526095_bib65","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.nbd.2004.08.011","article-title":"ApoE isoform-specific effects on LTP: Blockade by oligomeric amyloid-\u03b21\u201342","volume":"18","author":"Trommer","year":"2005","journal-title":"Neurobiol. Dis"},{"key":"10.1074\/jbc.M113.526095_bib66","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.chemphyslip.2005.06.005","article-title":"Isoform-specific interactions of human apolipoprotein E to an intermediate conformation of human Alzheimer amyloid-\u03b2 peptide","volume":"137","author":"Stratman","year":"2005","journal-title":"Chem. Phys. Lipids"},{"key":"10.1074\/jbc.M113.526095_bib67","doi-asserted-by":"crossref","first-page":"E1807","DOI":"10.1073\/pnas.1220484110","article-title":"ApoE influences amyloid-\u03b2 (A\u03b2) clearance despite minimal apoE\/A\u03b2 association in physiological conditions","volume":"110","author":"Verghese","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.M113.526095_bib68","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1158\/1535-7163.MCT-05-0322","article-title":"Organ-specific expression profiles of rat mammary gland, liver, and lung tissues treated with targretin, 9-cis retinoic acid, and 4-hydroxyphenylretinamide","volume":"5","author":"Wang","year":"2006","journal-title":"Mol. Cancer Ther"},{"key":"10.1074\/jbc.M113.526095_bib69","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1126\/science.1235505","article-title":"Comment on \u201cApoE-directed therapeutics rapidly clear \u03b2-amyloid and reverse deficits in AD mouse models\u201d","volume":"340","author":"Veeraraghavalu","year":"2013","journal-title":"Science"},{"key":"10.1074\/jbc.M113.526095_bib70","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1126\/science.1233937","article-title":"Comment on \u201cApoE-directed therapeutics rapidly clear \u03b2-amyloid and reverse deficits in AD mouse models\u201d","volume":"340","author":"Tesseur","year":"2013","journal-title":"Science"},{"key":"10.1074\/jbc.M113.526095_bib71","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1126\/science.1234089","article-title":"Comment on \u201cApoE-directed therapeutics rapidly clear \u03b2-amyloid and reverse deficits in AD mouse models\u201d","volume":"340","author":"Price","year":"2013","journal-title":"Science"},{"key":"10.1074\/jbc.M113.526095_bib72","doi-asserted-by":"crossref","first-page":"924-c","DOI":"10.1126\/science.1235809","article-title":"Comment on \u201cApoE-directed therapeutics rapidly clear \u03b2-amyloid and reverse deficits in AD mouse models\u201d","volume":"340","author":"Fitz","year":"2013","journal-title":"Science"},{"key":"10.1074\/jbc.M113.526095_bib73","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1750-1326-8-18","article-title":"Treatment with bexarotene, a compound that increases apolipoprotein-E, provides no cognitive benefit in mutant APP\/PS1 mice","volume":"8","author":"LaClair","year":"2013","journal-title":"Mol. Neurodegener"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820483450?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820483450?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.M113.526095","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T17:18:24Z","timestamp":1641316704000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925820483450"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":73,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S0021925820483450"],"URL":"https:\/\/doi.org\/10.1074\/jbc.m113.526095","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]}}}